12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Novo Integrated Sciences (NASDAQ:NVOS) stock rose 15.4% to $0.3 during Friday’s after-market session. Today’s trading volume for…
Stocks That Hit 52-Week Lows On Thursday
During the session on Thursday, 461 stocks hit new 52-week lows.
Genprex Inc. Receives Orphan Drug Designation For Immunogene Therapy For Treatment Of SCLC
Globe Newswire
NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire — Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers Allarity Therapeutics (NASDAQ:ALLR) shares increased by 31.5% to $2.13 during Wednesday’s after-market session. Allarity Therapeutics’s trading volume…
Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) rose 43% to $6.91.
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers enVVeno Medical (NASDAQ:NVNO) shares moved upwards by 29.4% to $4.71 during Wednesday’s regular session. Trading volume for…
Genprex Announces $7.5M Registered Direct Offering With An Instatutional Investor For The Sale And Issuance Of 7,425,744 Shares And Warrants At A Combined Price Of $1.01/Unit, Priced At-the-Market Under Nasdaq Rules
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers Biophytis (NASDAQ:BPTS) shares increased by 45.2% to $3.21 during Tuesday’s pre-market session. The market value of their…
Genprex Signs Exclusive License To Additional Diabetes Technology With The University Of Pittsburgh
Latest license creates a comprehensive panel of gene therapies exclusively licensed by Genprex for the Company's diabetes gene therapy program
Innovative program supported by preclinical data shows statistically
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived antibody and vaccine from Alzheimer's pipeline.